Table 1.
Patient characteristics of the study cohort
| Valid n | % | |
|---|---|---|
| Age (y) | ||
| Overall average | 49 | |
| Menopause status (n) | ||
| Premenopausal | 109 | 55.1 |
| Perimenopausal | 13 | 6.6 |
| Postmenopausal | 75 | 37.9 |
| Not specified | 1 | 0.5 |
| Tumor stadium (n) | ||
| Tis | 56 | 28.3 |
| T0 | 28 | 14.1 |
| T1 | 73 | 36.9 |
| T2 | 33 | 16.7 |
| T3 | 8 | 4.0 |
| Nodal status (n) | ||
| N0 | 154 | 77.8 |
| N1 | 30 | 15.2 |
| N2 | 6 | 3.0 |
| Nx | 8 | 4.0 |
| Metastatic status (n) | ||
| M0 | 131 | 66.2 |
| M1 | 2 | 1.0 |
| Mx | 65 | 32.8 |
| Grading (n) | ||
| G1 | 15 | 7.6 |
| G2 | 105 | 53 |
| G3 | 64 | 32.3 |
| Not specified | 14 | 7.1 |
| BCT before ablation (n) | ||
| No (primary) | 165 | 83.3 |
| Yes (secondary) | 33 | 16.7 |
| Indication ablation (n) | ||
| DCIS | 73 | 36.9 |
| IDC | 99 | 50.0 |
| ILC/ITC | 20 | 10.1 |
| Preventive ablation | 3 | 1.5 |
| Others | 3 | 1.5 |
| Type of ablatio (n) | ||
| SSM | 54 | 27.3 |
| NSM | 144 | 72.7 |
| Implant location (n) | ||
| Epipectoral | 117 | 59.1 |
| Subpectoral | 81 | 40.9 |
| Implant side (n) | ||
| Left | 99 | 50.0 |
| Right | 99 | 50.0 |
| Contralateral side (n) | ||
| No | 130 | 65.7 |
| Yes | 68 | 34.3 |